Why Cancer Patients Should Eat Less Sugar: The Hidden Link Between Sugar and Tumor GrowthMany cancer patients are told by doctors to “avoid sugar.” But why?Sugar is not poison—b...

Obesity has become a major global public health challenge. According to the World Obesity Federation, approximately 3 billion people worldwide were overweight or obese by 2024. Exc...

Eltromin (Eltrombopag) – Mechanism of Action and Therapeutic IndicationsEltromin, whose generic name is eltrombopag, is an oral thrombopoietin‑receptor agonist (TPO‑RA) widely...

The U.S. Food and Drug Administration (FDA) has officially approved Novartis’ latest gene replacement therapy, Itvisma, marking a significant milestone in the treatment landscape ...

Global Diabetes Situation: Over 1 in 10 Adults Affected, Prevention Is More Urgent Than EverDiabetes has long ceased being a disease confined to affluent nations—it has evolved in...

The U.S. Food and Drug Administration has granted approval to Otsuka’s newly developed injectable therapy for patients diagnosed with primary immunoglobulin A nephropathy (IgAN), ...

When people hear the word “generic drug,” they often think of cheap or low-quality medicine. In fact, this is a big misunderstanding. Generic drugs are not counterfeit medicines;...

When diagnosed with thrombocytopenia (low platelet count), many patients worry: “Does this mean I can’t live normally?” The answer is: you can, but your lifestyle will require s...

This page summarizes the latest approvals issued by the U.S. Food and Drug Administration (FDA). The list includes newly approved therapies as well as additional indications for ex...

September 30, 2025 — Gilead’s Epclusa (sofosbuvir/velpatasvir, 400mg/100mg) continues to reshape hepatitis C management worldwide. As the first and only all-oral, pan-genotypi...